This federal contract award, valued at $43,963.00, was issued by the Office of Naval Research (ONR) to Cambridge Isotope Laboratories, Inc., a foreign-owned, for-profit manufacturer of specialized isotopic compounds and materials. The contract is for the provision of IC 2775 methane-12C at 99.99 atom % purity, with a nitrogen impurity of 1 part per million. The contract is a firm fixed-price purchase order with a completion date of February 17, 2025. Cambridge Isotope Laboratories has a...
This federal contract award was issued by the National Institute of Environmental Health Sciences (NIEHS), a civilian agency within the Department of Health and Human Services (HHS), to Cambridge Isotope Laboratories, Inc. (doing business as Cambridge Isotope Labs), a foreign-owned, for-profit manufacturer of specialized chemicals and materials. The $22,977.00 firm-fixed-price purchase order is for the supply of 60 units of deuterium oxide packaged in 100 1-liter bottles, including a recovery...
This is a $235,092.20 firm fixed-price purchase order awarded by the Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse to MedChemExpress LLC, a New Jersey-based provider of biochemicals and other life science research materials. The contract is for the delivery of a custom chemical library of 84 items to the National Center for Advancing Translational Sciences (NCATS) to support its COVID-19 research. No set-aside designation was used. As a...
This is a $77,287.50 firm-fixed-price definitive contract awarded by the U.S. Air Force Research Laboratory (AFRL) to The Cambridge Crystallographic Data Centre (CCDC), a not-for-profit organization based in the United Kingdom. The contract is for a software license to access the Cambridge Structural Database (CSD), a comprehensive repository of small molecule crystal structures used in materials science, drug discovery, and structural chemistry research. This contract does not have a...
This firm fixed price purchase order awards Enamine LTD $230,323.60 to provide the National Center for Advancing Translational Sciences two general GPCR libraries totaling 27,000 compounds at $5.20 per compound. The libraries will support the National Institutes of Health's National Institute on Drug Abuse in identifying and developing novel small molecule leads against human disease targets through screening of thousands of compounds. One library will contain a minimum of 25,000 general GPCR...
Specs Chemical Services, Inc. was awarded a $900,000 firm fixed price purchase order by the National Institutes of Health's National Center for Advancing Translational Sciences to deliver a curated collection of over 6,000 screening compounds based on the Broad Institute Repurposing Set. The compounds will support the Center's drug discovery efforts by enabling screening and identification of potential drug candidates. As requested in the solicitation, Specs Chemical Services will provide the...
This is a $80,000.00 firm-fixed-price purchase order awarded by the National Institute on Drug Abuse (NIDA), part of the Department of Health and Human Services, to Cambridge Isotope Laboratories, Inc. (doing business as Cambridge Isotope Labs). The contract is for the provision of stable isotopes and isotope-labeled compounds to support ongoing biomedical research programs at NIDA and other National Institutes of Health (NIH) institutes such as the National Institute of Diabetes and Digestive...
The National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH), awarded a $141,500 firm-fixed-price purchase order to Chemdiv, Inc. for the acquisition of an 11,000 compound methyltransferase library. This non-competitive award was made under simplified acquisition procedures without a set-aside designation. The contract required delivery of the compound library within 8 weeks. Chemdiv, Inc. is a for-profit organization providing drug...
This is a firm fixed price purchase order awarded by the National Institutes of Health (NIH) National Institute on Drug Abuse (NIDA) to Cyprotex US LLC, a foreign-owned for-profit organization, for $152,060.00 to provide testing of small molecule compounds. The work is being performed in Watertown, Massachusetts and aligns with the agency's testing and assessment of potential drug compounds. The original solicitation was competed among small businesses, but the contract was not set aside....
Chemogenics Biopharma, LLC has been awarded a $23,540 firm fixed price purchase order by the National Institutes of Health's National Center for Advancing Translational Sciences to evaluate the pharmacokinetics of aldometanib in mice. Under the non-competitive contract, Chemogenics will determine aldometanib concentrations in various tissues through synthesis of the compound following a multistep sequence and analytical methods to analyze aldometanib levels. The company will also report and...